Partners4Access represented at World Orphan Drug Congress
The World Orphan Drug Congress in Brussels in November was the another conference Partners4Access attended. This year’s agenda focused on the challenges orphan drug manufacturers are facing in the regulatory and HTA environment. Topics as “value for money of orphan medicines” is a challenge our clients are facing every day. High profile health economists discussed…